Ftse Mib
34.447,57
0,87%
DAX
18.496,79
0,12%
S&P 500
5.235,48
-0,60%
NASDAQ
16.737,08
-1,08%
Bitcoin
68.363,30
1,15%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Integrated BioPharma Inc (QX) (INBP) Integrated BioPharma Inc (QX) (INBP) Notizie

INBP

Integrated BioPharma (QX) (INBP)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:INBP
DataOraFonteTitoloSimboloCompagnia
10/05/202422:39Edgar (US Regulatory)Form 8-K - Current reportUSOTC:INBPIntegrated BioPharma Inc (QX)
10/05/202422:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:INBPIntegrated BioPharma Inc (QX)
30/11/202300:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INBPIntegrated BioPharma Inc (QX)
16/11/202322:18Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipUSOTC:INBPIntegrated BioPharma Inc (QX)
16/11/202322:13Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesUSOTC:INBPIntegrated BioPharma Inc (QX)
16/11/202319:49Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:INBPIntegrated BioPharma Inc (QX)
27/10/202317:31Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:INBPIntegrated BioPharma Inc (QX)
15/09/202322:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:INBPIntegrated BioPharma Inc (QX)
01/06/202320:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:INBPIntegrated BioPharma Inc (QX)
11/05/202321:38Edgar (US Regulatory)Current Report Filing (8-k)USOTC:INBPIntegrated BioPharma Inc (QX)
10/02/202322:35Edgar (US Regulatory)Quarterly Report (10-q)USOTC:INBPIntegrated BioPharma Inc (QX)
14/11/202223:43Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:INBPIntegrated BioPharma Inc (QX)
11/05/202220:38Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:INBPIntegrated BioPharma Inc (QX)
02/09/202122:20AllPennyStocks.comBiotech Rallies On Bullish EarningsUSOTC:INBPIntegrated BioPharma Inc (QX)
02/09/202119:56Edgar (US Regulatory)Annual Report (10-k)USOTC:INBPIntegrated BioPharma Inc (QX)
17/11/202020:32Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:INBPIntegrated BioPharma Inc (QX)
28/10/202018:52Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:INBPIntegrated BioPharma Inc (QX)
28/12/201821:57Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:INBPIntegrated BioPharma Inc (QX)
16/02/201623:10Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:INBPIntegrated BioPharma Inc (QX)
13/02/201417:35Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:INBPIntegrated BioPharma Inc (QX)
12/02/201423:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)USOTC:INBPIntegrated BioPharma Inc (QX)
06/11/201322:28Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)USOTC:INBPIntegrated BioPharma Inc (QX)
06/11/201322:25Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:INBPIntegrated BioPharma Inc (QX)
27/11/201219:51Edgar (US Regulatory)Annual Report (management Company) (nsar-b)USOTC:INBPIntegrated BioPharma Inc (QX)
27/11/201219:50Edgar (US Regulatory)Current report filing (8-K)USOTC:INBPIntegrated BioPharma Inc (QX)
19/11/201223:28Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:INBPIntegrated BioPharma Inc (QX)
14/11/201221:09Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:INBPIntegrated BioPharma Inc (QX)
05/11/201218:23Edgar (US Regulatory)Amended Fidelity Bond Filed Pursuant to Rule 17g-1(g)(1) of the Investment Company Act of 1940 (40-17g/a)USOTC:INBPIntegrated BioPharma Inc (QX)
29/10/201211:04Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)USOTC:INBPIntegrated BioPharma Inc (QX)
15/10/201223:07Edgar (US Regulatory)Annual Report (10-K)USOTC:INBPIntegrated BioPharma Inc (QX)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:INBP

La tua Cronologia

BITV
ICPEUR
Internet Computer
EU
SESL
SES-imagotag
BIT
I06870
Intesa Sanpaolo
USOTC
ORESF
Orestone Mining (PK)
ASX
QBEKOX
NYSE
EDE
Empire Electric
USOTC
PWBK
Pacific West Bancorp (PK)
HITB
UNCBTC
UniGame UniCoin
COIN
ESGGGUST
ESG Global
LSE
ZIP
Zone-ip
UNSW3
CAGUSDT
Change
USOTC
GZTGF
G City (PK)
BOV
BBDCG183
BBDCG183 Ex:17,77
BOV
QUAL3R
QUALICORP ON
COIN
ABETEUR
USOTC
GMRSF
GME Resources (GM)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network